Protective Efficacy of the Calicivirus Valency of the Leucofeligen Vaccine against a Virulent Heterologous Challenge in Kittens

Table 2

Cumulative clinical scores (CS) using the scoring system as defined in Table 1 for the individual cats during the first week after challenge.

Cat ID group V	Cumulative CS Week 1 (pct0 to pct7)	NAb at challenge	Cat ID group C	Cumulative CS Week 1 (pct0 to pct7)	NAb at challenge
1	12	(−)	1	10	(−)
2	3	(−)	2	11	(−)
3	0	+	3	13	(−)
4	1	+	4	8	(−)
5	1	(−)	5	8	(−)
6	4	(−)	6	29	(−)
7	1	+	7	12	(−)
8	4	+	8	7	(−)
9	6	+	9	16	(−)
10	1	(−)	10	18	(−)
Median	2.0		Median	11.5
Q25%; Q75%	1.0; 4.0		Q25%; Q75%	8.0; 16.0
Mean; [95% CI]	3.3; [0.7; 5.9]		Mean; [95% CI]	13.2; [8.5; 17.9]